|
OMNICOMM SYSTEMS, INC. EXPERIENCES RECORD YEAR END RESULTS - $18 MILLION IN
SIGNED CONTRACTS FOR THE YEAR 2008
FT. LAUDERDALE, FL – January 16, 2009 – /PR Newswire/ - OmniComm
Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data
capture solutions for clinical trials, today announced record breaking results for
2008 in new and repeat business that exceeded original expectations. A record jump
of 80% in contracts over 2007 clearly validates OmniComm’s position as a major contender
in the EDC Marketplace.
“OmniComm has worked hard to build a strong foundation of superior products and
services for our customers,” said Stephen Johnson, COO of OmniComm. “We recognize
the importance of our clients’ business and are working diligently to deliver the
integrated solutions that they need to succeed. In the very near future, our plans
include the introduction of our own IVRS tool, IVRMaster, that will seamlessly integrate
with our EDC tool, TrialMasterTM to offer randomization, ePRO and supply
tracking. In early 2009, we will also be releasing our Clinical Data Hub product
to offer a more centralized and seamless aggregation of clinical data across multiple
systems. This solution will empower our clients to take better control of their
data and better leverage core industry standards like CDISC/CDASH, e2b and SDTM.”
Added CFO, Ronald Linares, “We are pleased that we were able to increase our revenues
during 2008 during what was a difficult year in the macro-economy. More importantly,
we have diversified our client mix to include larger Bio-tech firms and have successfully
begun deploying our product on a licensed basis.”
OmniComm continues to increase its customer base with a strong mix of new customer
business coupled with steady, recurring business from its existing loyal customers.
The following is a breakdown of business for 2008.
Milestones for 2008:
- 60 New Business Deals Including:
- 4 Pharmaceutical Companies
- 20 Biotechnology Companies
- 11 Medical Device Companies
- 7 Academic Institutions
- 14 Contract Research Organizations (CROs)
- 4 Consulting Projects
- Introduced eLearning tool in July of 2007. Over 250 site users have successfully
completed TrialMaster eLearning certification since the initial launch. The company
recently released TrialMaster eLearning version 1.1, which includes an additional
9 lessons and certification focused on training Site Monitors and internal sponsor
personnel.
- 2 Technology Transitions and 1 Technology Transfer for EDC
- Increased employee headcount from 77 to 85 FTEs
- 28 CRO Preferred Program Partners
- Expanded European office to include help desk support in seven languages
About OmniComm
OmniComm Systems, Inc. (www.OmniComm.com)
provides customer-driven Internet solutions to pharmaceutical, biotechnology, research
and medical device organizations that conduct life changing clinical trial research.
OmniComm’s growing base of satisfied customers is a direct result of the company’s
commitment to deliver products and services that ensure ease of use, faster study
build, ease of integration and better performance. OmniComm’s client intuitive pricing
model allows companies that range from small, to mid-size to large scale institutions
to safely and efficiently capitalize on their clinical research investments. OmniComm
Systems, Inc. has corporate headquarters in Ft. Lauderdale, Florida with offices
in Bonn, Germany, Tula, Russia, California, Maryland, New York, North Carolina and
Texas.
Safe Harbor Disclaimer
Statements about OmniComm’s future expectations, including without limitation, future
revenues and earnings, plans and objectives for the future operations, future agreements,
future economic performance, operations and all other statements in this press release
other than historical facts are "forward-looking statements" within the meaning
of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Securities Litigation Reform
Act of 1995. OmniComm intends that such forward-looking statements be subject to
the Safe Harbors created thereby. Since these statements involve risks and uncertainties,
including but not limited to economic competitive, governmental, contractual and
technological factors affecting OmniComm’s operations, markets and profitability,
actual results could differ materially and adversely from the expected results.
CONTACT:
Lizanne Kelley
OmniComm Systems, Inc.
954-473-1254 Extension 283
lkelley@omnicomm.com
Back
|
